ZUR VIRALEN KARZINOGENESE BEIM MENSCHEN. RNS-TUMORVIRUS-AEHNLICHE STRUKTUREN IN MENSCHLICHEN LEUKAEMIEN, LYMPHOMEN UND SARKOMEN = CARCINOGENESE VIRALE CHEZ L'HOMME. STRUCTURES IDENTIQUES AUX ARN DE VIRUS TUMORAUX DANS LES LEUCEMIES HUMAINES, LYMPHOMES ET SARCOMESHEHLMANN R.1980; FORTSCHR. MED.; ISSN 0015-8178; DEU; DA. 1980; VOL. 98; NO 38; PP. 1473-1476; ABS. ENGArticle

HIV-Infektion. Verlaufsformen und Definitionen = Infection par HIV: évolution et définition = HIV infection: courses and definitionsHEHLMANN, R.AIDS - Forschung. 1988, Vol 3, Num 1, pp 41-44, issn 0179-3098Article

HUMAN LEUKEMIA VIRUSES. RNA TUMOR VIRUSES, HUMAN MALIGNANCIES, AND CONCEPTS OF VIRAL CARCINOGENESISHEHLMANN R; ERFLE V.1980; BLUT; ISSN 0006-5242; DEU; DA. 1980; VOL. 41; NO 4; PP. 247-256; BIBL. 57 REF.Article

Current CML therapy: progress and dilemmaHEHLMANN, R.Leukemia. 2003, Vol 17, Num 6, pp 1010-1012, issn 0887-6924, 3 p.Article

ELISA FOR THE DETECTION AND QUANTIFICATION OF C-TYPE VIRAL GLYCOPROTEIN (GP 70) USING ANTIBODIES THAT RECOGNIZE THE PROTEIN MOIETIES OF THE GLYCOPROTEINSSCHETTERS H; HEHLMANN R; ERFLE V et al.1981; J. VIROL. METHODS; ISSN 0166-0934; NLD; DA. 1981; VOL. 2; NO 6; PP. 357-366; BIBL. 17 REF.Article

Comparative research in leukemia and related diseases. An introduction to a scientific approachHEHLMANN, R; ESSEX, M.Leukemia. 1999, Vol 13, pp 19-28, issn 0887-6924, SUP1Conference Paper

PARTICLES FROM MOUSE MELANOMA B16 CONTAINING RESERVE TRANSCRIPTASE AND 70S RNA RELATED TO HUMAN MELANOMA CYTOPLASMIC RNAHEHLMANN R; BALDA BR; SPIEGELMAN S et al.1978; ARCH. DERMATOL. RES.; DEU; DA. 1978; VOL. 262; NO 2; PP. 157-165; ABS. GER; BIBL. 1 P.Article

VIRAL-RELATED RNA IN HODGKIN'S DISEASE AND OTHER HUMAN LYMPHOMASHEHLMANN R; KUFE D; SPIEGELMAN S et al.1972; PROC. NATION. ACAD. SCI., U.S.A.; U.S.A.; DA. 1972; VOL. 69; NO 7; PP. 1727-1731; BIBL. 16REF.Serial Issue

TIME COURSE OF C-TYPE RETROVIRUS EXPRESSION IN MICE SUBMITTED TO OSTEOSARCOMAGENIC DOSES OF ²²⁴RADIUMERFLE V; HEHLMANN R; SCHETTERS H et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 26; NO 1; PP. 107-113; BIBL. 1 P.Article

DETECTION OF GROUP AND INTERSPECIES REACTIVITIES OF MAMMALIAN C-TYPE VIRUS P30 PROTEINS BY AN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA): ENHANCEMENT OF INTERSPECIES REACTIVITY BY DENATURATIONSCHETTERS H; HEHLMANN R; ERFLE V et al.1982; JOURNAL OF VIROLOGICAL METHODS; ISSN 0166-0934; NLD; DA. 1982; VOL. 5; NO 3-4; PP. 181-190; BIBL. 17 REF.Article

DETECTION AND QUANTIFICATION OF TYPE C VIRAL PROTEINS IN TISSUES AND SERA WITH AN ENZYME IMMUNOASSAYSCHETTERS H; HEHLMANN R; ERFLE V et al.1980; INFECT. IMMUN.; ISSN 0019-9567; USA; DA. 1980; VOL. 29; NO 3; PP. 972-980; BIBL. 21 REF.Article

IDIOPATHIC REFRACTORY SIDEROACHRESTIC ANEMIA (IRSA) PROGRESSING TO ACUTE MIXED LYMPHOBLASTIC-MYELOMONOBLASTIC LEUKEMIAHEHLMANN R; ZOENNCHEN B; THIEL E et al.1983; BLUT; ISSN 0006-5242; DEU; DA. 1983; VOL. 46; NO 1; PP. 11-21; BIBL. 37 REF.Article

ONCORNAVIRUS-LIKE PARTICLES IN HUMAN SKIN CANCERSBALDA BR; HEHLMANN R; CHO JR et al.1975; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1975; VOL. 72; NO 9; PP. 3697-3700; BIBL. 18 REF.Article

DETECTION AND BIOCHEMICAL CHARACTERIZATION OF ANTIGENS IN HUMAN LEUKEMIC SERA THAT CROSSREACT WITH PRIMATE C-TYPE VIRAL PROTEINS (M_R 30,000) = DETECTION ET CARACTERISATION BIOCHIMIQUE DES ANTIGENES DANS LES SERUMS LEUCEMIQUES HUMAINS QUI DONNENT UNE REACTION CROISEE AVEC LES PROTEINES VIRALES DE TYPE C DE PRIMATES (MR 30.000)HEHLMANN R; SCHETTERS H; ERFLE V et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 1; PP. 392-399; ABS. ENG; BIBL. 31 REF.; GRAPH, FIGArticle

Current trends in the management of chronic myelogenous leukemiaHEHLMANN, R; HOCHHAUS, A; BERGER, U et al.Annals of hematology (Print). 2000, Vol 79, Num 7, pp 345-354, issn 0939-5555Article

The Charlotte Friend Memorial Lecture. The role of hematopoietic growth factors in the development and suppression of myeloid leukemiasMETCALF, D.Leukemia. 1999, Vol 13, pp 8-13, issn 0887-6924, SUP1Conference Paper

Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia : Inverse correlation between expression and tumor progressionKHALDOYANIDI, S; ACHTNICH, M; HEHLMANN, R et al.Leukemia research. 1996, Vol 20, Num 10, pp 839-851, issn 0145-2126Article

Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamineHEHLMANN, R; SCHMITZ, H; KRÜGER, K et al.International journal of cardiology. 1984, Vol 5, Num 6, pp 749-753, issn 0167-5273Article

HUMAN CANCER AND THE RNA TUMOR VIRUSESSPIEGELMAN S; AXEL R; BAXT W et al.1972; IN: FED. EUR. BIOCHEM. SOC. 8TH. MEET.; AMSTERDAM; 1972; AMSTERDAM; NORTH-HOLLAND; DA. 1972; VOL. 27; PP. 73-99; BIBL. 29REF.Conference Proceedings

Comparative research on leukemia and related diseases : An introduction to a scientific approachHEHLMANN, R; ESSEX, M.Journal of molecular medicine (Berlin. Print). 1997, Vol 75, Num 7, pp 528-538, issn 0946-2716Conference Paper

Interferon α in the treatment of polycythemia veraLENGFELDER, E; BERGER, U; HEHLMANN, R et al.Annals of hematology (Print). 2000, Vol 79, Num 3, pp 103-109, issn 0939-5555Article

Methodological problems in comparing incidence and prevalence of leukaemias and lymphomas : ascertainment and age adjustmentHAKULINEN, T.Leukemia. 1999, Vol 13, pp 37-41, issn 0887-6924, SUP1Conference Paper

Quantitative determination of retrovirus-specific immune complexesSCHETTERS, H; ROHMER, H; HEHLMANN, R et al.Journal of immunological methods. 1990, Vol 134, Num 1, pp 113-119, issn 0022-1759Article

Essential thrombocythemia: clinical characteristics and course of 61 casesHEHLMANN, R; JAHN, M; BAUMANN, B et al.Cancer. 1988, Vol 61, Num 12, pp 2487-2496, issn 0008-543XArticle

Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitorsSAUSSELE, S; HEHLMANN, R; GRATWOHL, A et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 2, issn 0268-3369, p. 304Article